ArticleBMC medical imaging2026
Hybrid 2D/3D CNN and radiomics model for brain tumor classification using EfficientNetb0 and ResNet-18.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain tumors, caused by rapid and uncontrolled cellular proliferation, pose significant health risks worldwide. Accurate and early classification of tumor types such as Glioblastoma, IDH-wildtype, grade 4, Meningioma, and Brain Metastasis is crucial for improving treatment outcomes. This study combines Radiomic features with advanced deep learning models, including EfficientNet-B0 and ResNet-18, to classify 2D and 3D brain tumor images effectively. The classifiers, particularly MLP and CatBoost, demonstrated robust performance, achieving macro F1-scores of 86% and 84%, respectively. However, the imbalanced dataset posed challenges in classification accuracy for less represented classes, emphasizing the need for comprehensive evaluation using AUC and ROC analyses. Additionally, SHAP analysis revealed that texture heterogeneity features, especially original_gldm_DependenceNonUniformityNormalized, consistently contributed significantly across tumor types. Model uncertainty assessment showed that brain metastasis was the most confidently predicted class in both models, meningioma classification had higher confidence in MLP, and Glioblastoma, IDH-wildtype was predicted more reliably by CatBoost. These findings highlight the complementary strengths of combining Radiomics and deep learning for enhanced brain tumor classification and underscore the value of uncertainty quantification in model evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.